Functional screening of lysosomal storage disorder genes identifies modifiers of alpha-synuclein neurotoxicity
Open Access
- 18 May 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 19 (5) , e1010760
Abstract
Heterozygous variants in the glucocerebrosidase (GBA) gene are common and potent risk factors for Parkinson’s disease (PD). GBA also causes the autosomal recessive lysosomal storage disorder (LSD), Gaucher disease, and emerging evidence from human genetics implicates many other LSD genes in PD susceptibility. We have systemically tested 86 conserved fly homologs of 37 human LSD genes for requirements in the aging adult Drosophila brain and for potential genetic interactions with neurodegeneration caused by α-synuclein (αSyn), which forms Lewy body pathology in PD. Our screen identifies 15 genetic enhancers of αSyn-induced progressive locomotor dysfunction, including knockdown of fly homologs of GBA and other LSD genes with independent support as PD susceptibility factors from human genetics (SCARB2, SMPD1, CTSD, GNPTAB, SLC17A5). For several genes, results from multiple alleles suggest dose-sensitivity and context-dependent pleiotropy in the presence or absence of αSyn. Homologs of two genes causing cholesterol storage disorders, Npc1a / NPC1 and Lip4 / LIPA, were independently confirmed as loss-of-function enhancers of αSyn-induced retinal degeneration. The enzymes encoded by several modifier genes are upregulated in αSyn transgenic flies, based on unbiased proteomics, revealing a possible, albeit ineffective, compensatory response. Overall, our results reinforce the important role of lysosomal genes in brain health and PD pathogenesis, and implicate several metabolic pathways, including cholesterol homeostasis, in αSyn-mediated neurotoxicity.Keywords
Funding Information
- National Institute on Aging (U01AG061357, R01AG057339, R21AG068961)
- Huffington Foundation
- Burroughs Wellcome Fund (Career Award for Medical Scientists)
- Effie Marie Cain Chair in Alzheimer’s Research
- Terry and Bob Lindsay
- Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital
- National Institute of Neurological Disorders and Stroke (F31NS115364)
- Parkinson's Disease Foundation (PF-PRF-830012)
- Alzheimer's Association (AARF-21-848017)
- National Institutes of Health (P30CA125123)
This publication has 74 references indexed in Scilit:
- Crag Is a GEF for Rab11 Required for Rhodopsin Trafficking and Maintenance of Adult Photoreceptor CellsPLOS Biology, 2012
- An integrative approach to ortholog prediction for disease-focused and other functional studiesBMC Bioinformatics, 2011
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in SynucleinopathiesCell, 2011
- Cholesterol Oxidation Products Are Sensitive and Specific Blood-Based Biomarkers for Niemann-Pick C1 DiseaseScience Translational Medicine, 2010
- Lysosomal Degradation of α-Synuclein in VivoJournal of Biological Chemistry, 2010
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseNew England Journal of Medicine, 2009
- Cathepsin D Is the Main Lysosomal Enzyme Involved in the Degradation of α-Synuclein and Generation of Its Carboxy-Terminally Truncated SpeciesBiochemistry, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- A genome-wide transgenic RNAi library for conditional gene inactivation in DrosophilaNature, 2007